Evidence map›Paper›PMID 25735869›Full record

ReviewJournal of the International AIDS Society2015

The HIV care cascade: models, measures and moving forward.

Sarah MacCarthy, Michael Hoffmann, Laura Ferguson, Amy Nunn, Risha Irvin, David Bangsberg, Sofia Gruskin, Ines Dourado

Registry-linked trialOpen access · goldAbstract readReview
In one paragraph

Review in Journal of the International AIDS Society, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02692027 (Same Day Community-based ART Initiation Versus Clinic-based Pre-ART Assessment and Counselling for Individuals Newly Tested HIV-positive During Community-based HIV Testing in Rural Lesotho - a Randomized Controlled Trial), which is not on this map. Cited by 64 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
64citing papers in PubMed, 3 pooled it
8.3field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02692027 phase3completednot on this mapstarted 2016, after this paper: background citation

Same Day Community-based ART Initiation Versus Clinic-based Pre-ART Assessment and Counselling for Individuals Newly Tested HIV-positive During Community-based HIV Testing in Rural Lesotho - a Randomized Controlled Trial

TypeinterventionalSponsorSwiss Tropical & Public Health InstituteRan2016 to 2018Enrolled276ConditionsHIV InfectionArmsSame-day ART initiation, Standard of care
3 · Its place in the literature

Who cites it

64 citing papers in PubMed, 3 syntheses or guidelines pooled it, 106 citations in OpenAlex.

  1. Pooled it
  2. Rapid initiation of antiretroviral therapy for people living with HIV.The Cochrane database of systematic reviews · 2019
    Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

4 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 6 institutions in 2 countries.

Sarah MacCarthyRAND Corporation, Santa Monica, CA, USA; sarahm@rand.org.
Michael HoffmannDivision of Infectious Diseases, The Miriam Hospital, Alpert Medical School of Brown University, Providence, RI, USA.
Laura FergusonProgram on Global Health and Human Rights, Institute for Global Health, University of Southern California, Los Angeles, CA, USA.
Amy NunnDivision of Infectious Diseases, The Miriam Hospital, Alpert Medical School of Brown University, Providence, RI, USA.
Risha IrvinDivision of Infectious Diseases, Johns Hopkins University, Baltimore, MD, USA.
David BangsbergCenter for Global Health, Massachusetts General Hospital, Boston, MA, USA.
Sofia GruskinProgram on Global Health and Human Rights, Institute for Global Health, University of Southern California, Los Angeles, CA, USA.
Ines DouradoInstitute of Collective Health, Federal University of Bahia, Salvador, Brazil.
Brown University · USUniversity of Southern California · USHarvard University · USJohns Hopkins University · USRAND Corporation · USUniversidade Federal da Bahia · BR

Funding

Vaccine Response and Immunotherapeutics SWGP30AI094189 · NIAID · JOHNS HOPKINS UNIVERSITY · PI Bryan Lau · 2012 to 2026
$67.0M
Translational ScienceP30AI042853 · NIAID · MIRIAM HOSPITAL · PI CURT G BECKWITH · 1998 to 2026
$51.7M
HIV and Other Infectious Consequences of Substance UseT32DA013911 · NIDA · MIRIAM HOSPITAL · PI TRACI C GREEN, JOSIAH D RICH · 2001 to 2026
$9.6M
UCLA Implementation Science and Substance Use Research and Education (ISSURE) ProgramR25DA035692 · NIDA · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI TIMOTHY W FONG, GAIL E. WYATT · 2013 to 2026
$3.9M
Brown NIMHD Minority Health & Health Disparities International Research TrainingT37MD008655 · NIMHD · BROWN UNIVERSITY · PI FLANIGAN, TIMOTHY P · 2014 to 2018
$1.2M
NIAID NIH HHS P30 AI042853NIAID NIH HHS P30 AI094189NIAID NIH HHS P30AI094189NIDA NIH HHS 1R25 DA035692NIDA NIH HHS R25 DA035692NIDA NIH HHS T32 DA013911NIDA NIH HHS T32 DA12911-12NIMHD NIH HHS 1T37MD008655NIMHD NIH HHS T37 MD008655
6 · The paper itself

Abstract

introductionThis article seeks to identify where delays occur along the adult HIV care cascade ("the cascade"), to improve understanding of what constitutes "delay" at each stage of the cascade and how this can be measured across a range of settings and to inform service delivery efforts. Current metrics are reviewed, measures informed by global guidelines are suggested and areas for further clarification are underscored. DISCUSSION: Questions remain on how best to evaluate late entry into each stage of the cascade. The delayed uptake of HIV testing may be more consistently measured once rapid CD4 testing is administered at the time of HIV testing. For late enrollment, preliminary research has begun to determine how different time intervals for linking to HIV care affect individual health. Regarding treatment, since 2013, the World Health Organization (WHO) and UNAIDS recommend treatment initiation when CD4 <500 cells/mm(3); these guidelines provide a useful albeit evolving threshold to define late treatment initiation. Finally, WHO guidelines for high-, low- and middle-income countries also could be used to standardize measures for achieving viral suppression.

conclusionsThere is no "one size fits all" model as the provision of services may differ based on a range of factors. Nonetheless, measures informed by global guidelines are needed to more consistently evaluate the scope of and factors associated with delays to each stage of the cascade. Doing so will help identify how practitioners can best deliver services and facilitate access to and continued engagement in care.

Indexed as

AdultHIV InfectionsHumansPractice Guidelines as Topiccare cascadecontinuum of careHIV/AIDSlinkage to caremeasurestestingtreatment cascadeviral suppression

Identifiers

PMID25735869
PMCPMC4348400
OpenAlexW2157619698

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.